Dr. Itakura is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
300 Pasteur Dr
Stanford, CA 94305Phone+1 650-498-5710
Education & Training
- University of Pennsylvania Health SystemResidency, Internal Medicine, 1999 - 2002
- Jacobs School of Medicine and Biomedical Sciences at the University at BuffaloClass of 1999
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Hematology
- Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology
- Stanford UniversityPhD, Biomedical Informatics
Certifications & Licensure
- CA State Medical License 2001 - 2025
- PA State Medical License 2000 - 2002
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
- American Board of Preventive Medicine Clinical Informatics
Clinical Trials
- Permission to Collect Blood Over Time for Research Start of enrollment: 2008 Aug 01
- The GORE Viabahn Endoprosthesis for the Treatment of Venous Occlusions and Stenoses Start of enrollment: 2010 Dec 01
Publications & Presentations
PubMed
- 191 citationsMagnetic resonance image features identify glioblastoma phenotypic subtypes with distinct molecular pathway activitiesHaruka Itakura, Achal S. Achrol, Lex A. Mitchell, Joshua Loya, Tiffany Ting Liu
Science Translational Medicine. 2015-09-02 - 17 citationsDo plasma biomarkers of coagulation and fibrinolysis differ between patients who have experienced an acute myocardial infarction versus stable exertional anginaHaruka Itakura, Burton E. Sobel, Derek B. Boothroyd, Lawrence L.K. Leung, Carlos Iribarren
American Heart Journal. 2007-12-01 - 9 citationsAntimicrobial exposure is associated with decreased survival in triple-negative breast cancer.Julia D Ransohoff, Victor Ritter, Natasha Purington, Karen Andrade, Summer Han
Nature Communications. 2023-04-12
Press Mentions
- Susan G. Komen® Invests $21.7 Million in Research Focused on Improving Outcomes for Breast Cancer PatientsJune 22nd, 2022
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: